News

As earlier outlined, short-term studies in animals and humans have shown GLP-1 to have some direct vasorelaxation ... outcomes in patients receiving GLP1-RA therapy. There are no published studies ...
FAT JABS have taken the nation’s waistline by storm – trimming inches and helping thousands shed weight, and fast. But it ...
GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...
GLP-1 RAs are associated with a significant decrease in apnea-hypopnea index among patients with moderate to severe OSA and without diabetes.
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
For patients with diabetes, exposure to GLP-1 RAs is associated with an increased risk for incident neovascular AMD development.
Get Instant Summarized Text (Gist) GLP-1 receptor agonists are safe and effective for weight loss and glycemic control in adults with severe mental illness, including those on psychotropic medications ...
Primary care practices are seeing an uptick in patients inquiring about glucagon-like peptide 1 receptor agonist (GLP-1 RA) medications due to both media hype and sizzle-reel stories they see on ...
Share on Pinterest A new study shows GLP-1 drugs liraglutide, exenatide, and dulaglutide were 41% more effective at preventing obesity-related cancers. Carsten Snejbjerg/Bloomberg via Getty Images ...
While GLP-1 receptor agonists like semaglutide help with ... They were also asked about GLP-RA use, including the specific drug, reasons for use, duration, side effects, and expected period ...
GLP-1 drugs are increasingly used to treat obesity in adults. They can also be used in children from the age of 12 and clinical trials have shown children lose 5-16% of their body weight after a ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with severe mental illness, as well as having positive effects ...